Valneva SE VALN recently applied for a label extension to the FDA to potentially extend the use of its chikungunya vaccine, IXCHIQ. Currently approved for adults, the vaccine may soon be accessible to ...
The alleged harm of Covid-vaccinations is a topic that still leads to misunderstandings, perhaps nowhere more than in the realm of so-called alternative medicine. Therefore, this paper seems relevant.